Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001909803 | SCV002185654 | uncertain significance | not provided | 2023-12-28 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with histidine, which is basic and polar, at codon 99 of the PDX1 protein (p.Pro99His). This variant is present in population databases (rs764870332, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of Type 2 diabetes and/or healthy controls (PMID: 21569088). ClinVar contains an entry for this variant (Variation ID: 1408111). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PDX1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002490245 | SCV002800958 | uncertain significance | Maturity-onset diabetes of the young type 4; Pancreatic agenesis 1; Type 2 diabetes mellitus | 2021-11-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001909803 | SCV005333215 | uncertain significance | not provided | 2024-02-02 | criteria provided, single submitter | clinical testing | Reported in a patient with diabetes mellitus type 2 and the control group in published literature (PMID: 21569088); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 32041611, 21569088) |